THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION

This adverse event was reported 371 times

These drugs are most commonly taken by patients reporting THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION:

# Drug Count
0 DICLOFENAC SODIUM 44
1 NAPROXEN SODIUM 29
2 DUPILUMAB 28
3 NAPROXEN SODIUM TABLET 26
4 DICLOFENAC 15
5 GUAIFENESIN 15
6 LAMOTIRIGINE 12
7 LAMOTRIGINE 12
8 LAMOTRIGINE CHEWABLE DISPERSIBLE 12
9 LAMOTRIGINE EXTENDED-RELEASE 12
See all common drugs associated with THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION

THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LEFAMULIN ACETATE 1 0.0588
1 WHITE PETROLATUM MINERAL OIL 1 0.0345
2 CHLORPHENIRAMINE MALEATE, IBUPROFEN, PSEUDOEPHEDRINE HCL 1 0.0042
3 IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE 3 0.0030
4 OLANZAPINE AND SAMIDORPHAN L-MALATE 5 0.0030
5 ODEVIXIBAT 1 0.0025
6 CAMPHOR, CAPSAICIN, MENTHOL 1 0.0019
7 MENTHOL, UNSPECIFIED FORM 1 0.0016
8 BEPOTASTINE BESILATE 1 0.0016
9 IVERMECTIN 7 0.0015
See all drugs enriched for association with THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION